Clinical Trial Update: A Study Of PF-06664178 In Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of PF-06664178 in patients with advanced solid tumors was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• PF-06664178

Snippet

Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2018-02-19